Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multi-site Trial of a Point of Care Saliva Based Detection Test Based on Soluble CD44 (OncAlert) for Presence of Disease in Previously Untreated Oral Cavity and Oropharynx Squamous Cell Carcinoma

NCT03148665 is registered in ClinicalTrials.gov with Joseph Califano as lead sponsor.

NCT NCT03148665
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03148665 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multi-site Trial of a Point of Care Saliva Based Detection Test Based on Soluble CD44 (OncAlert) for Presence of Disease in Previously Untreated Oral Cavity and Oropharynx Squamous Cell Carcinoma
Lead sponsor
Joseph Califano
Phase
Observational
Overall status
Completed
Start date
April 14, 2017
Completion date
May 3, 2022
Enrollment
85 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

oral cavity squamous cell carcinoma, oropharynx squamous cell carcinoma, squamous cell carcinoma of the head and neck, squamous cell carcinoma of the oropharynx